Abbott designed the Volt PFA catheter for maneuverability, efficient ablation and thermal risk mitigation, said Dr.

Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation (“PFA”) system to treat patients battling atrial fibrillation (AFib). The development came earlier than expected, ...

The system, which has received CE Mark approval in Europe, adds to an increasingly crowded field of PFA technologies.

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

Though late to the party compared to other industry leaders, Abbott joins a pulsed field ablation market poised for significant growth.

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation Pulsed field ablation – or PFA – uses high energy ...

(RTTNews) - Abbott (ABT) Thursday announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark ...

The Volt PFA System is a new therapy for heart rhythm disorders like AFib. It uses high-energy electrical pulses for ablation procedures that target and treat heart tissue. Abbott said in a press ...

Abbott (NYSE: ABT), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $219.58 billion, has received CE Mark approval for its Volt PFA System ...